|Articles|July 11, 2012
Drug Cost Control in Oncology
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis
4
Never-Screened Cervical Cancer Rates Climb Among US Women
5